These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21749985)

  • 1. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
    Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
    Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
    Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
    Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
    Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electronic nose in the discrimination of patients with asthma and controls.
    Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen E; Wouters EF; Van Schooten FJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):101-7. PubMed ID: 18055279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
    Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
    Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.
    Robroeks CM; van Berkel JJ; Jöbsis Q; van Schooten FJ; Dallinga JW; Wouters EF; Dompeling E
    Eur Respir J; 2013 Jul; 42(1):98-106. PubMed ID: 23645402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study.
    King J; Mochalski P; Kupferthaler A; Unterkofler K; Koc H; Filipiak W; Teschl S; Hinterhuber H; Amann A
    Physiol Meas; 2010 Sep; 31(9):1169-84. PubMed ID: 20664160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children.
    Dallinga JW; Robroeks CM; van Berkel JJ; Moonen EJ; Godschalk RW; Jöbsis Q; Dompeling E; Wouters EF; van Schooten FJ
    Clin Exp Allergy; 2010 Jan; 40(1):68-76. PubMed ID: 19793086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
    van der Schee MP; Palmay R; Cowan JO; Taylor DR
    Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.
    Schleich FN; Zanella D; Stefanuto PH; Bessonov K; Smolinska A; Dallinga JW; Henket M; Paulus V; Guissard F; Graff S; Moermans C; Wouters EFM; Van Steen K; van Schooten FJ; Focant JF; Louis R
    Am J Respir Crit Care Med; 2019 Aug; 200(4):444-453. PubMed ID: 30973757
    [No Abstract]   [Full Text] [Related]  

  • 19. Volatile biomarkers of pulmonary tuberculosis in the breath.
    Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
    Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology.
    Caldeira M; Barros AS; Bilelo MJ; Parada A; Câmara JS; Rocha SM
    J Chromatogr A; 2011 Jun; 1218(24):3771-80. PubMed ID: 21546028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.